Cefotaxime
Cefotaxime
CLINICAL USE
Antibacterial agent
DOSE IN NORMAL RENAL FUNCTION
Mild infection: 1 g every 12 hoursModerate infection: 1 g every 8 hoursSevere infection: 2 g every 6 hoursLife-threatening infection: up to 12 g daily in 3–4 divided doses PHARMACOKINETICS
Molecular weight                           :477.4 (as sodium salt) %Protein binding                           :40 %Excreted unchanged in urine     : 40–60 Volume of distribution (L/kg)       :0.15–0.55half-life – normal/ESRD (hrs)      :0.9–1.14/2.5 (10 hours for the metabolite) DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : 1 g every 8–12 hours DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in GFR <10 mL/min HD                     :Dialysed. Dose as in GFR <10           : mL/min HDF/high flux   :Dialysed. Dose as in GFR <10           : mL/min CAV/VVHD      :Dialysed. 1–2 g every 12 hours
CVVhd/HDFDialysed. 2 g every 12 hours1 IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnticoagulants: effects of coumarins may be enhanced ADMINISTRATION
Reconstition
IV Bolus/IM: 4 mL water for injection to 1 gIV Infusion: 1 g in 50 mL sodium chloride 0.9% Route
IV, IM Rate of Administration
Bolus over 3–4 minutes; infusion over 20–60 minutesComments
– OTHER INFORMATION
1 g contains 2.09 mmol sodium Reduce dose further if concurrent hepatic and renal failure
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home